Both in Pharmaceuticals
AbCellera Biologics vs Disc Medicine
Over the past year ABCL returned +152.2% and IRON returned −3.2%; their daily moves had a correlation of 0.22.
ABCL +152.2% IRON −3.2%Growth of $1, one year, split-adjusted
| Metric | ABCL | IRON |
|---|---|---|
| Price | $12.28 | $83.28 |
| Market cap | $3.98B | $3.70B |
| Today | +0.82% | +2.61% |
| 1 month | −6.6% | +35.1% |
| 6 months | +143.7% | +21.3% |
| Year to date | +259.1% | +4.9% |
| 1 year | +128.7% | −1.7% |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −1368.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 60.1× | — |
| Net cash | $540.1M | $658.4M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 75.9% |
| Short % of float | 14.5% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).